Monte Rosa Therapeutics (GLUE) Return on Assets (2023 - 2025)
Monte Rosa Therapeutics' Return on Assets history spans 3 years, with the latest figure at 0.09% for Q4 2025.
- For Q4 2025, Return on Assets fell 2.0% year-over-year to 0.09%; the TTM value through Dec 2025 reached 0.09%, down 2.0%, while the annual FY2025 figure was 0.09%, 2.0% down from the prior year.
- Return on Assets reached 0.09% in Q4 2025 per GLUE's latest filing, down from 0.17% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.2% in Q2 2025 to a low of 0.49% in Q4 2023.
- Average Return on Assets over 3 years is 0.16%, with a median of 0.09% recorded in 2025.
- The largest YoY upside for Return on Assets was 62bps in 2025 against a maximum downside of -2bps in 2025.
- A 3-year view of Return on Assets shows it stood at 0.49% in 2023, then surged by 87bps to 0.06% in 2024, then crashed by -38bps to 0.09% in 2025.
- Per Business Quant, the three most recent readings for GLUE's Return on Assets are 0.09% (Q4 2025), 0.17% (Q3 2025), and 0.2% (Q2 2025).